Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Sorafenib
Related studies linked through entity extraction aliases.
Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.
- Status
- COMPLETED
- Phase
- PHASE1
First Line Hepato Cellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Sorafenib in Patients With Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Sorafenib and Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)
- Status
- UNKNOWN
- Phase
- PHASE2
Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin Treatment
- Status
- UNKNOWN
- Phase
- PHASE2
Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Sorafenib/Cetuximab in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Sorafenib in Treating Patients With Advanced Malignant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib in Previously Treated Malignant Mesothelioma
- Status
- UNKNOWN
- Phase
- PHASE2
Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2